Evidence map›Paper›PMID 41066574›Full record

ArticleScience (New York, N.Y.)2025

mRNA initiation and termination are spatially coordinated.

Ezequiel Calvo-Roitberg, Christine L Carroll, GyeungYun Kim, Valeria Sanabria, Sergey V Venev, Steven T Mick, Joseph D Paquette, Maritere Uriostegui-Arcos, Job Dekker, Ana Fiszbein and 1 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases.Computational and structural biotechnology journal · 2026
    Review
  11. bioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ezequiel Calvo-Roitberg *RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-2431-515X
Christine L Carroll *Department of Biology, Boston University, Boston, MA, USA.ORCID 0009-0005-9992-6296
GyeungYun KimDepartment of Biology, Boston University, Boston, MA, USA.ORCID 0000-0003-4382-503X
Valeria SanabriaRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-3138-2393
Sergey V VenevDepartment of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-1507-7460
Steven T MickDepartment of Biology, Boston University, Boston, MA, USA.ORCID 0000-0002-7781-7831
Joseph D PaquetteRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0009-0004-8536-8951
Maritere Uriostegui-ArcosDepartment of Biology, Boston University, Boston, MA, USA.
Job DekkerDepartment of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-5631-0698
Ana Fiszbein *Department of Biology, Boston University, Boston, MA, USA.ORCID 0000-0002-4190-5901
Athma A Pai *RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-7995-9948

Funding

Structural Annotation of the Human GenomeR01HG003143 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Job Dekker · 2003 to 2026
$15.4M
Center for 3D Structure and Physics of the GenomeUM1HG011536 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DEKKER, JOB, MIRNY, LEONID A · 2020 to 2024
$11.8M
Tracking transcriptome diversity in real-timeR35GM133762 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Athma A Pai · 2019 to 2026
$3.3M
A kinetic framework to map the genetic determinants of alternative RNA isoform expressionR01HG012967 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Barbara Engelhardt, Athma A Pai · 2023 to 2026
$3.0M
Probing co-transcriptional gene regulatory logics in human transcriptomesR35GM147254 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Ana Fiszbein · 2022 to 2026
$2.1M
NHGRI NIH HHS R01 HG003143NHGRI NIH HHS R01 HG012967NHGRI NIH HHS UM1 HG011536NIGMS NIH HHS R35 GM133762NIGMS NIH HHS R35 GM147254
6 · The paper itself

Abstract

Transcriptional initiation and termination decisions drive messenger RNA (mRNA) isoform diversity but the relationship between them remains poorly understood. By systematically profiling joint usage of transcription start and end sites, we observed that mRNA using upstream starts preferentially use upstream end sites and that the usage of downstream sites is similarly coupled. Our results suggest a positional initiation termination axis (PITA), in which usage of alternative terminal sites are coupled based on their genomic order. PITA is enriched in longer genes with distinct chromatin features. We find that mRNA 5' start choice directly influences 3' ends depending on RNA polymerase II trafficking speed. Our results indicate that spatial organization and transcriptional dynamics couple transcription initiation and mRNA 3' end decisions to define mRNA isoform expression.

Indexed as

RNA, MessengerTranscription Initiation, GeneticTranscription Initiation SiteTranscription Termination, GeneticChromatinHumansRNA IsoformsRNA Polymerase IIChromatinRNA IsoformsRNA, MessengerRNA Polymerase II

Identifiers

PMID41066574
PMCPMC12649799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.